| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1248722C Medicine for treating coronary heart disease and preparation method thereof |
| 04/05/2006 | CN1248711C Chinese herbal medicine for treating hypertension |
| 04/05/2006 | CN1248702C Chinese medicine preparation for treating coronary heart disease and angina pectoris and its preparation process |
| 04/05/2006 | CN1248700C Health-care food for preventing and treating hyperlipoidemia |
| 04/05/2006 | CN1248698C Drug for treating coronary heart disease or coronary disease complicated by cardiac insufficiency and its preparation method |
| 04/05/2006 | CN1248695C Composition with blood pressure regulating function and its product and preparing method |
| 04/05/2006 | CN1248691C Controlled release peroral compositions of levosimendan |
| 04/05/2006 | CN1248690C Oral preparation containing ranolazine hydrochloride for treating cardiovascular disease |
| 04/05/2006 | CN1248684C Chinese medicine powder for treating cardiovascular and cerebrovascular disease and preparing method thereof |
| 04/04/2006 | US7024217 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022723 Heterocyclic compounds |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022710 A1 adenosine receptor antagonists |
| 04/04/2006 | US7022709 Producing pharmaceuticals for improving perception, concentration, learning and/or memory. |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022678 Pregabalin lactose conjugates |
| 04/04/2006 | US7022676 obtained by hydrolysis of casein; hypotensive agentsl; for use in foods and drugs |
| 04/04/2006 | US7022521 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 04/04/2006 | US7022343 In situ polymerization on heart; biodegradation |
| 04/04/2006 | US7022322 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure |
| 04/04/2006 | US7022064 Cardiac support with controlled ventricular pressure |
| 04/04/2006 | CA2356544C Pyridotriazines and pyridopyridazines |
| 04/04/2006 | CA2354123C New benzothiadiazine derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 04/04/2006 | CA2188507C Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 03/30/2006 | WO2006033631A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 03/30/2006 | WO2006033630A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | WO2006033287A1 PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND GLUTATHIONE |
| 03/30/2006 | WO2006033004A1 Quinoline compounds as cetp inhibitors |
| 03/30/2006 | WO2006032386A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide |
| 03/30/2006 | WO2006032372A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 03/30/2006 | WO2006032115A2 Composition against cardiovascular diseases |
| 03/30/2006 | WO2006014864A3 Methods and compositions for reducing c-reactive protein |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069410 Method and system for terminating an atrial arrhythmia |
| 03/30/2006 | US20060069259 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069156 Acylated aminopropanediols and analogues and therapeutic uses thereof |
| 03/30/2006 | US20060069146 Cardiovascular disordders; antiarrhythmia agents; neurodegenerative diseases; antidepressants; bipolar disorders; irritable bowel disorders |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069117 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/30/2006 | US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/30/2006 | US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060069028 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 03/30/2006 | US20060069018 Treating lung diseases selected from acute pneumonia, pulmonary fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and asthma by administering (E)-[5-[2-[1-phenyl-1-(3-pyridyl)methylideneaminoxy]ethyl]-7,8-dihydronaphthalen-1-yloxy]acetic acid or a salt thereof |
| 03/30/2006 | US20060069014 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 03/30/2006 | US20060068043 Aqueous solution of flavonoids and anthocyanins |
| 03/30/2006 | US20060068027 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 03/30/2006 | US20060067982 Encasing a core made of a siloxane-based elastomer containing dexamethasone, betamethasone, beclomethasone, and/or budesonide with a membrane made of the same or a different elastomer; and shaping the device into a shape suitable for implantation into the ear or nose |
| 03/30/2006 | US20060067934 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067928 Contacting a linear polysaccharide with a disaccharide repeat unit of a uronic acid [ alpha -L-iduronic acid (I) or beta -D-glucuronic acid] linked 1, 4 to alpha -D-hexosamine with a modified heparinase III in vitro |
| 03/30/2006 | DE102004044555A1 New modification of 2-indenylbutyric acid derivative, useful for treating e.g. diabetes and obesity, thermodynamically stable at room temperature |
| 03/30/2006 | CA2619256A1 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 03/30/2006 | CA2582507A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | CA2581175A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 03/30/2006 | CA2581081A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide |
| 03/30/2006 | CA2580975A1 Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| 03/30/2006 | CA2580924A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 03/30/2006 | CA2521421A1 C-mycer.tam. induced human neural stem cell lines |
| 03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640447A1 BIOACTIVE PEPTIDE-PRODUCING STRAINS OF i ENTEROCOCCUS FAECALIS /i , BIOACTIVE PEPTIDES AND APPLICATIONS THEREOF |
| 03/29/2006 | EP1640381A2 Neurotrophic growth factor |
| 03/29/2006 | EP1640369A1 Thiazolimine compound and oxazolimine compound |
| 03/29/2006 | EP1640039A1 Adjustable, non-electric liquid air-freshener device |
| 03/29/2006 | EP1640020A1 Cardioprotective agent |
| 03/29/2006 | EP1640005A2 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin B6 |
| 03/29/2006 | EP1640001A1 Composition against cardiovascular diseases |
| 03/29/2006 | EP1639006A1 Use of a vegf receptor gene or gene product |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638947A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 03/29/2006 | EP1638576A1 Combination of acetylsalicylic acid and alpha-glucosidase inhibitors |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1638548A1 Preventing atrial fibrillation (af) with the use of statin drugs |
| 03/29/2006 | EP1638528A2 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy |
| 03/29/2006 | EP1638525A2 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 03/29/2006 | EP1638460A1 Directing cells to target tissues or organs |
| 03/29/2006 | EP1523311B1 Calcium lactate and whey permeate for lowering the triglyceride level |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |